Citation Impact
Citing Papers
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
1996
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase.
1995
The human fatty acid-binding protein family: Evolutionary divergences and functions
2011
Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men
2003
Genetic factors affecting blood lipoproteins: the candidate gene approach.
1988
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
1990 Standout
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Nitric oxide and atherosclerosis: An update
2006 Nobel
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
2005
Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
1995
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
2020
Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life, and Cardiovascular Risk
2007
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
1991 Standout
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
2009 Standout
Cellular survival: a play in three Akts
1999 Standout
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR
1996
Diabetic dyslipidaemia: from basic research to clinical practice*
2003
Tumor suppressor genes
1991 Standout
Genomic organization of major sperm protein genes and pseudogenes in the nematode Caenorhabditis elegans
1988 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
1990 StandoutNature
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Chronic kidney disease
2011 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes
2002
Diabetes and Atherosclerosis
2002 Standout
A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus
1989
Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis
2007
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Endothelial function and coronary artery disease
2001
The hormone resistin links obesity to diabetes
2001 StandoutNature
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Regulation of free radical outflow from an isolated muscle bed in exercising humans
2004
The Human Obesity Gene Map: The 2003 Update
2004
Atherosclerosis
2000 StandoutNature
DNA polymorphisms of the apolipoprotein genes — their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis
1988
Localization of a locus for Charcot-Marie-Tooth neuropathy type la (CMT1A) to chromosome 17
1990
Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease
1999
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
2014
The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients
1999
DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects
1989
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
2000
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Hybridization of nucleic acids immobilized on solid supports
1984
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis
1999
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
1992 StandoutScience
Beneficial Effects of Fenofibrate to Improve Endothelial Dysfunction and Raise Adiponectin Levels in Patients With Primary Hypertriglyceridemia
2005
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM)
1989
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
2010
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter
1984 Standout
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
2001
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
1996
Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation
2002
Mitochondrial DNA and human evolution
1987 StandoutNature
Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma.
1989
African Populations and the Evolution of Human Mitochondrial DNA
1991 StandoutScience
Pleiotropic loss of activation pathways in a T-cell receptor α-chain deletion variant of a cytolytic T-cell clone
1987 StandoutNatureNobel
The Lipoprotein Lipase Hin dIII Polymorphism Modulates Plasma Triglyceride Levels in Visceral Obesity
1995
Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistance
2010
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.
1988 StandoutNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
A polymorphism (G–>A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency
1994
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Close linkage of the mouse and human CD3 gamma- and delta-chain genes suggests that their transcription is controlled by common regulatory elements.
1987 StandoutNobel
Hypervariable ‘minisatellite’ regions in human DNA
1985 StandoutNature
Mechanisms of Diabetic Complications
2013 Standout
A Polymorphic Locus Near the Human Insulin Gene Is Associated with Insulin-dependent Diabetes Melliitus
1984
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
1992 StandoutNobel
Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4).
1986
DNA restriction fragment length polymorphisms and heterozygosity in the human genome
1984
daf-2 , an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans
1997 StandoutScienceNobel
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
2004
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
1988 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Creatine and Creatinine Metabolism
2000 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII.
1984
Works of A. Rees being referenced
The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency
2000
The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes
2001
The influence of the Pro12Ala mutation of the PPAR‐gamma receptor gene on metabolic and clinical characteristics in treatment‐naïve patients with type 2 diabetes
2002
Diabetic dyslipidaemia and coronary heart disease
1999
DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia
1985
Chromosome 4q Locus Associated With Insulin Resistance in Pima Indians: Studies in Three European NIDDM Populations
1994
Ciprofibrate Therapy Improves Endothelial Function and Reduces Postprandial Lipemia and Oxidative Stress in Type 2 Diabetes Mellitus
2000
A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia
1986
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.
1994
haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia
1986
Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.
1985
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.
1992
DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA
1983
Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin
2003
DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis
1985
A DNA polymorphism adjacent to the human apolipoprotein CII gene.
1983